Re-Establishment of a Normal Apoptotic Process as a Therapeutic Approach in B-CLL

E-ISSN： 1875-5895|3|4|261-286

ISSN： 1568-0061

Source： Current Drug Targets - Cardiovascular & Hematological Disorders, Vol.3, Iss.4, 2003-12, pp. : 261-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The angiogenic status of B-CLL B cells: role of the VEGF receptors

By Kay N.E.

Leukemia Research, Vol. 28, Iss. 3, 2004-03 ,pp. : 221-222

Elsevier

Access to resources Recommend Favorite

Simvastatin induces apoptosis of B-CLL cells by activation of mitochondrial caspase 9

By Chapman-Shimshoni D. Yuklea M. Radnay J. Shapiro H. Lishner M.

Experimental Hematology, Vol. 31, Iss. 9, 2003-09 ,pp. : 779-783

Elsevier

Access to resources Recommend Favorite

Molecular Cytogenetic Analysis of B-CLL Patients with Aggressive Disease

By Gozzetti Alessandro Crupi Rosaria Tozzuoli Daniela Raspadori Donatella Forconi Francesco Lauria Francesco

Hematology, Vol. 9, Iss. 5-6, 2004-10 ,pp. : 383-385

Maney Publishing

Access to resources Recommend Favorite

Development of a Richter syndrome with a monoclonal component from a true B-cell chronic lymphocytic leukemia (B-CLL) treated with fludarabine

By Bernasconi Paolo Paulli Marco Orlandi Ester Perfetti Vittorio Giardini Ilaria Zibellini Silvia Vanelli Laura Tenore Anna Algarotti Alessandra Boni Marina Amici Mara Brusamolino Ercole Lazzarino Mario

Annals of Hematology, Vol. 86, Iss. 8, 2007-08 ,pp. : 619-622

Springer Publishing Company

Access to resources Recommend Favorite

The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL)

By Junevik Katarina Werlenius Olle Hasselblom Sverker Jacobsson Stefan Nilsson-Ehle Herman Andersson Per-Ola

Annals of Hematology, Vol. 86, Iss. 2, 2007-02 ,pp. : 89-94

Springer Publishing Company

Access to resources Recommend Favorite